short information on flu and the annual vaccination for people of age 60+ in germany
also available in german, turkish, russian, arabic on
https://www.bzga.de/infomaterialien/impfungen-und-persoenlicher-infektionsschutz/grippeimpfung/grippeimpfung-der-richtige-schritt-fuer-einen-sicheren-schutz/...
more
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.14
HIV patient monitoring and case surveillance
PQDx 0141-051-00 WHO
PQDx Public Report
April/2017, version 5.0
LEAVING NO-ONE BEHIND | “A Journey to End NTDs – Elimination and Care” records what we have achieved over the last year and where we are now. It presents our plan of action for the coming years, bringing our ‘traditional’ NTD work together with ‘Disease Management Disability and Inclusio...n’ (DMDI), Community Based Inclusive Development (CBID) and Livelihoods. We care for those affected and we’re working to enhance community and government ownership through national
health system strengthening, community engagement and cross-sectoral action. Ultimately, we are working to free future generations from these menacing diseases, improving prevention and treatment, without forgetting those for whom prevention and treatment are too late because they already have a disability.
more
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.12
Topics in Antiviral Medicine Volume 25 Issue 2 May/June 2017
HIV Treatment
Policy Brief
July 2017
This is a basic form for reporting individual cases of plague. It asks for information regarding patient history and the course of the illness. In addition, it offers space for laboratory results, the case status, and epidemiological information.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more